Trupanion CFO 10b5-1 Sale of 6,451 Shares; Weighted Avg $45.15
Rhea-AI Filing Summary
Trupanion, Inc. (TRUP) Form 4 summary: Chief Financial Officer Fawwad Qureshi reported the exercise and sale of 6,451 shares of Trupanion common stock on 09/02/2025 under a Rule 10b5-1 trading plan adopted May 19, 2025, for financial diversification. The shares were sold in multiple transactions at prices ranging from $44.79 to $45.67, with a reported weighted-average price of $45.1548.
The filing shows 0 shares beneficially owned by the reporting person following the sale. The reporting person states the plan removed discretion over timing of transactions; further details on individual trade quantities by price are available upon request to the issuer or SEC staff.
Positive
- Transaction executed under a Rule 10b5-1 plan, indicating preplanned timing and reduced insider-timing concerns
- Weighted-average price and price range disclosed, and filer offers to provide detailed breakdown on request for transparency
Negative
- Reporting person holds 0 shares following the sale, which may reduce perceived management-shareholder alignment
Insights
TL;DR: CFO executed a preplanned 10b5-1 sale of 6,451 shares and now reports zero beneficial ownership.
The sale was conducted under a documented Rule 10b5-1 plan adopted May 19, 2025, which limits insider timing discretion and provides an affirmative defense under insider trading rules. Reporting a weighted-average price and a disclosed price range aligns with common transparency practices. The immediate drop to 0 shares beneficially owned is noteworthy for governance observers because officers holding no equity can affect perceived alignment with shareholders. However, the presence of the 10b5-1 plan reduces regulatory concern about trading-window timing.
TL;DR: Transaction appears procedurally compliant: 10b5-1 plan, multiple trades, weighted-average price disclosed.
The Form 4 discloses an S code sale of 6,451 common shares on 09/02/2025 at a weighted-average price of $45.1548, with individual trade prices between $44.79 and $45.67. The filer commits to provide breakdown of shares sold at each price on request, which supports auditability. From a compliance perspective, the filing contains the expected explanatory footnotes and an attorney-in-fact signature, indicating proper execution and filing protocol.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 6,451 | $45.1548 | $291K |
Footnotes (1)
- The exercise and sale reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on May 19, 2025, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.7900 to $45.6700 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2).
